Breast conservation therapy: The influence of molecular subtype and margins

International Journal of Radiation Oncology Biology Physics

Volumn 83, Issue 3, 2012, Pages 814-820

  Demirci, Senem ^a,b   Broadwater, Gloria ^c,d   Marks, Lawrence B ^e   Clough, Robert ^a   Prosnitz, Leonard R ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b EGE UNIVERSITY   (Turkey)

^c DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d DUKE CANCER INSTITUTE   (United States)

^e UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

Breast cancer; Breast conservation therapy; Margin status; Molecular subtypes; Prognostic factors

Indexed keywords

BREAST CANCER; BREAST CONSERVATION THERAPY; MARGIN STATUS; MOLECULAR SUBTYPES; PROGNOSTIC FACTORS;

DISEASES; HOSPITALS; PATIENT MONITORING;

PATIENT TREATMENT;

ADULT; AGED; ARTICLE; BREAST CANCER; BREAST SURGERY; CANCER CONTROL; CANCER RADIOTHERAPY; CANCER SURGERY; CANCER SURVIVAL; EARLY CANCER; FAILURE FREE SURVIVAL; HUMAN; MAJOR CLINICAL STUDY; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGNOSIS; RETROSPECTIVE STUDY; TREATMENT OUTCOME;

ADOLESCENT; ADULT; AGED; ANALYSIS OF VARIANCE; BREAST NEOPLASMS; COMBINED MODALITY THERAPY; FEMALE; HUMANS; MASTECTOMY, SEGMENTAL; MIDDLE AGED; NEOPLASM STAGING; NEOPLASM, RESIDUAL; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE; RETROSPECTIVE STUDIES; TUMOR MARKERS, BIOLOGICAL; YOUNG ADULT;

EID: 84861608272     PISSN: 03603016     EISSN: 1879355X     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2011.09.001     Document Type: Article

References (37)

1. M. Clarke, R. Collins, and S. Darby Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: An overview of the randomised trials Lancet 366 2005 2087 2106
2. S.J. Anderson, I. Wapnir, and J.J. Dignam Prognosis after ipsilateral breast tumor recurrence and locoregional recurrences in patients treated by breast-conserving therapy in five National Surgical Adjuvant Breast and Bowel Project protocols of node-negative breast cancer J Clin Oncol 27 2009 2466 2473
3. B.G. Haffty, Q. Yang, and M. Reiss Locoregional relapse and distant metastasis in conservatively managed triple negative early-stage breast cancer J Clin Oncol 24 2006 5652 5657
4. M. Mannino, and J.R. Yarnold Local relapse rates are falling after breast conserving surgery and systemic therapy for early breast cancer: Can radiotherapy ever be safely withheld? Radiother Oncol 90 2009 14 22
5. S. MacDonald, and A.G. Taghian Prognostic factors for local control after breast conservation: Does margin status still matter? J Clin Oncol 27 2009 4929 4930
6. G. Freedman, B. Fowble, and A. Hanlon Patients with early stage invasive cancer with close or positive margins treated with conservative surgery and radiation have an increased risk of breast recurrence that is delayed by adjuvant systemic therapy Int J Radiat Oncol Biol Phys 44 1999 1005 1015
7. J.J. Jobsen, J. Van Der Palen, and F. Ong Differences in outcome for positive margins in a large cohort of breast cancer patients treated with breast-conserving therapy Acta Oncol 46 2007 172 180
8. A.C. Neuschatz, T. DiPetrillo, and H. Safaii Long-term follow-up of a prospective policy of margin-directed radiation dose escalation in breast-conserving therapy Cancer 97 2003 30 39
9. E. Obedian, and B.G. Haffty Negative margin status improves local control in conservatively managed breast cancer patients Cancer J Sci Am 6 2000 28 33
10. C.C. Park, M. Mitsumori, and A. Nixon Outcome at 8 years after breast-conserving surgery and radiation therapy for invasive breast cancer: Influence of margin status and systemic therapy on local recurrence J Clin Oncol 18 2000 1668 1675
11. M.E. Peterson, D.J. Schultz, and C. Reynolds Outcomes in breast cancer patients relative to margin status after treatment with breast-conserving surgery and radiation therapy: The University of Pennsylvania experience Int J Radiat Oncol Biol Phys 43 1999 1029 1035
12. S.E. Singletary Surgical margins in patients with early-stage breast cancer treated with breast conservation therapy Am J Surg 184 2002 383 393
13. F.A. Vicini, N.S. Goldstein, and H. Pass Use of pathologic factors to assist in establishing adequacy of excision before radiotherapy in patients treated with breast-conserving therapy Int J Radiat Oncol Biol Phys 60 2004 86 94
14. A.C. Voogd, M. Nielsen, and J.L. Peterse Differences in risk factors for local and distant recurrence after breast-conserving therapy or mastectomy for stage I and II breast cancer: Pooled results of two large European randomized trials J Clin Oncol 19 2001 1688 1697
15. H.A. Jones, N. Antonini, and A.A. Hart Impact of pathological characteristics on local relapse after breast-conserving therapy: A subgroup analysis of the EORTC boost versus no boost trial J Clin Oncol 27 2009 4939 4947
16. L.A. Carey, C.M. Perou, and C.A. Livasy Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study JAMA 295 2006 2492 2502
17. C. Sotiriou, and L. Pusztai Gene-expression signatures in breast cancer N Engl J Med 360 2009 790 800
18. J.S. Parker, M. Mullins, and M.C. Cheang Supervised risk predictor of breast cancer based on intrinsic subtypes J Clin Oncol 27 2009 1160 1167
19. M.C. Cheang, S.K. Chia, and D. Voduc Ki67 index, HER2 status, and prognosis of patients with luminal B breast cancer J Natl Cancer Inst 101 2009 736 750
20. M. Cianfrocca, and W. Gradishar New molecular classifications of breast cancer CA Cancer J Clin 59 2009 303 313
21. E.K. Millar, P.H. Graham, and S.A. O'Toole Prediction of local recurrence, distant metastases, and death after breast-conserving therapy in early-stage invasive breast cancer using a five-biomarker panel J Clin Oncol 27 2009 4701 4708
22. G.M. Freedman, P.R. Anderson, and T. Li Locoregional recurrence of triple-negative breast cancer after breast-conserving surgery and radiation Cancer 115 2009 946 951
23. M. Kyndi, F.B. Sorensen, and H. Knudsen Estrogen receptor, progesterone receptor, HER-2, and response to postmastectomy radiotherapy in high-risk breast cancer: The Danish Breast Cancer Cooperative Group J Clin Oncol 26 2008 1419 1426
24. J.M. Albert, A.M. Gonzalez-Angulo, and M. Guray Estrogen/progesterone receptor negativity and HER2 positivity predict locoregional recurrence in patients with T1a, bN0 breast cancer Int J Radiat Oncol Biol Phys 77 2010 1296 1302
25. P.L. Nguyen, A.G. Taghian, and M.S. Katz Breast cancer subtype approximated by estrogen receptor, progesterone receptor, and HER-2 is associated with local and distant recurrence after breast-conserving therapy J Clin Oncol 26 2008 2373 2378
26. K.D. Voduc, M.C. Cheang, and S. Tyldesley Breast cancer subtypes and the risk of local and regional relapse J Clin Oncol 28 2010 1684 1691
27. E.P. Mamounas, G. Tang, and B. Fisher Association between the 21-gene recurrence score assay and risk of locoregional recurrence in node-negative, estrogen receptor-positive breast cancer: Results from NSABP B-14 and NSABP B-20 J Clin Oncol 28 2010 1677 1683
28. L.B. Marks, M.E. Hebert, and G. Bentel To treat or not to treat the internal mammary nodes: A possible compromise Int J Radiat Oncol Biol Phys 29 1994 903 909
29. E. Kaplan, and P. Meier Nonparametric estimation from incomplete observations J Am Stat Assoc 53 1958 457 481
30. D.R. Cox, and D. Oakes Analysis of survival data 1984 Chapman & Hall London
31. R.W. Carlson, D.C. Allred, and B.O. Anderson Breast cancer. Clinical practice guidelines in oncology J Natl Compr Canc Netw 7 2009 122 192
32. T.A. Buchholz, S.L. Tucker, and J. Erwin Impact of systemic treatment on local control for patients with lymph node-negative breast cancer treated with breast-conservation therapy J Clin Oncol 19 2001 2240 2246
33. K.P. McGuire, A.A. Santillan, and P. Kaur Are mastectomies on the rise? A 13-year trend analysis of the selection of mastectomy versus breast conservation therapy in 5865 patients Ann Surg Oncol 16 2009 2682 2690
34. N. Antonini, H. Jones, and J.C. Horiot Effect of age and radiation dose on local control after breast conserving treatment: EORTC trial 22881-10882 Radiother Oncol 82 2007 265 271
35. T.J. Yang, Q. Yang, and B.G. Haffty Prognosis for mammographically occult, early-stage breast cancer patients treated with breast-conservation therapy Int J Radiat Oncol Biol Phys 76 2010 79 84
36. K.L. Miller, L.B. Marks, and R.C. Barrier Jr. Increased sectioning of pathologic specimens with ductal carcinoma in situ of the breast: Are there clinical consequences? Clin Breast Cancer 4 2003 198 202
37. L.J. Solin, S.G. Orel, and W.T. Hwang Relationship of breast magnetic resonance imaging to outcome after breast-conservation treatment with radiation for women with early-stage invasive breast carcinoma or ductal carcinoma in situ J Clin Oncol 26 2008 386 391